miRNAs as Probes to Monitor Cancer and Neurodegenerative Disorders
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (28 February 2014) | Viewed by 160062
Special Issue Editor
Interests: early diagnosis in cancer and neurodegenerative disorders by miRNAs detection; strategy both for diagnosis and therapy in order to efficaciously target the clinical disease and reduce the failure rate of pharmacological treatment
Special Issue Information
Dear Colleagues,
This Special Issue of Molecules "miRNAs as Probes to Monitor Cancer and Neurodegenerative Disorders" is devoted to outstanding research and review papers focused on new diagnostic methodology employing miRNAs detection. The aim is to set a miRNAs panel useful for a specific diagnosis of cancer and neurodegenerative onset. Moreover, these biomarkers could lead to therapeutic strategy plans for these pathologies that were reported as being the challenge for the scientific community over the next few years in the Horizon 2020 guidelines. We ask that authors contemplating submission of review papers provide a pre-submission inquiry to the guest editor with a brief outline of the proposed coverage.
Prof. Dr. Nicola Antonio Colabufo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- miRNAs
- multidrug resistance
- diagnosis AD
- therapy miRNA-modulated
- biomarkers
- early diagnosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.